Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrei Braester

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Hematological Oncology|February 14, 2019
Low-dose fludarabine and cyclophosphamide combined with standard dose rituximab (LD-FCR) is an effective and safe regimen for elderly untreated patients with chronic lymphocytic leukemia: The Israeli CLL study group experienceYair Herishanu, Tamar Tadmor, Andrei Braester, et al.
Annals of Hematology|August 23, 2016
Azacitidine-lenalidomide (ViLen) combination yields a high response rate in higher risk myelodysplastic syndromes (MDS)-ViLen-01 protocolMoshe Mittelman, Kalman Filanovsky, Yishai Ofran, et al.
Research and Practice in Thrombosis and Haemostasis|June 6, 2022
Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT studyJavier Trujillo-Santos, Dominique Farge-Bancel, José María Pedrajas, et al.
Mediterranean Journal of Hematology and Infectious Diseases|November 16, 2020
Peripheral Blood Cell Mitochondrial Dysfunction in Myelodysplastic Syndrome Can Be Improved by a Combination of Coenzyme Q10 and CarnitineKalman Filanovsky, Michal Haran, Vita Mirkin, et al.
Blood|December 3, 2021
Efficacy of a third BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL who failed standard 2-dose vaccinationYair Herishanu, Galia Rahav, Shai Levi, et al.
Thrombosis Research|November 10, 2015
Venous thromboembolism in patients with glioblastoma multiforme: Findings of the RIETE registryJose Portillo, Iris Violeta de la Rocha, Llorenç Font, et al.
Journal of Thrombosis and Thrombolysis|February 1, 2018
Anemia and bleeding in patients receiving anticoagulant therapy for venous thromboembolismAmir Kuperman, Raquel López-Reyes, Lopez-Saez Juan Bosco, et al.
Leukemia Research|September 15, 2015
Ruxolitinib treatment for myelofibrosis: Efficacy and tolerability in routine practiceMartin H Ellis, Noa Lavi, Elena Mishchenko, et al.
Hematological Oncology|June 23, 2017
Persistently low lymphocyte counts after FCR therapy for chronic lymphocytic leukemia are associated with longer overall survivalErel Joffe, N Ariela Arad, Osnat Bairey, et al.
Anticancer Research|November 7, 2018
Hairy Cell Leukemia: Retrospective Analysis of Demographic Data and Outcome of 203 Patients from 12 Medical Centers in IsraelMichal Inbar, Yair Herishanu, Neta Goldschmidt, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Hematological Oncology|February 14, 2019
Low-dose fludarabine and cyclophosphamide combined with standard dose rituximab (LD-FCR) is an effective and safe regimen for elderly untreated patients with chronic lymphocytic leukemia: The Israeli CLL study group experienceYair Herishanu, Tamar Tadmor, Andrei Braester, et al.
Annals of Hematology|August 23, 2016
Azacitidine-lenalidomide (ViLen) combination yields a high response rate in higher risk myelodysplastic syndromes (MDS)-ViLen-01 protocolMoshe Mittelman, Kalman Filanovsky, Yishai Ofran, et al.
Research and Practice in Thrombosis and Haemostasis|June 6, 2022
Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT studyJavier Trujillo-Santos, Dominique Farge-Bancel, José María Pedrajas, et al.
Mediterranean Journal of Hematology and Infectious Diseases|November 16, 2020
Peripheral Blood Cell Mitochondrial Dysfunction in Myelodysplastic Syndrome Can Be Improved by a Combination of Coenzyme Q10 and CarnitineKalman Filanovsky, Michal Haran, Vita Mirkin, et al.
Blood|December 3, 2021
Efficacy of a third BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL who failed standard 2-dose vaccinationYair Herishanu, Galia Rahav, Shai Levi, et al.
Thrombosis Research|November 10, 2015
Venous thromboembolism in patients with glioblastoma multiforme: Findings of the RIETE registryJose Portillo, Iris Violeta de la Rocha, Llorenç Font, et al.
Journal of Thrombosis and Thrombolysis|February 1, 2018
Anemia and bleeding in patients receiving anticoagulant therapy for venous thromboembolismAmir Kuperman, Raquel López-Reyes, Lopez-Saez Juan Bosco, et al.
Leukemia Research|September 15, 2015
Ruxolitinib treatment for myelofibrosis: Efficacy and tolerability in routine practiceMartin H Ellis, Noa Lavi, Elena Mishchenko, et al.
Hematological Oncology|June 23, 2017
Persistently low lymphocyte counts after FCR therapy for chronic lymphocytic leukemia are associated with longer overall survivalErel Joffe, N Ariela Arad, Osnat Bairey, et al.
Anticancer Research|November 7, 2018
Hairy Cell Leukemia: Retrospective Analysis of Demographic Data and Outcome of 203 Patients from 12 Medical Centers in IsraelMichal Inbar, Yair Herishanu, Neta Goldschmidt, et al.
Pageof 5